{"id":5180,"date":"2021-11-04T16:02:54","date_gmt":"2021-11-04T13:02:54","guid":{"rendered":"https:\/\/www.klimik.org.tr\/koronavirus\/?p=5180"},"modified":"2021-11-04T16:02:54","modified_gmt":"2021-11-04T13:02:54","slug":"covid-19a-karsi-gelistirilen-ilk-etkili-oral-antiviral-ilac-olan-molnupiravir-ilk-kullanim-onayini-da-aldi","status":"publish","type":"post","link":"https:\/\/www.klimik.org.tr\/koronavirus\/covid-19a-karsi-gelistirilen-ilk-etkili-oral-antiviral-ilac-olan-molnupiravir-ilk-kullanim-onayini-da-aldi\/","title":{"rendered":"COVID-19&#8217;a Kar\u015f\u0131 Geli\u015ftirilen \u0130lk Etkili Oral Antiviral \u0130la\u00e7 Olan Molnupiravir, \u0130lk Kullan\u0131m Onay\u0131n\u0131 da Ald\u0131"},"content":{"rendered":"<p><img decoding=\"async\" loading=\"lazy\" class=\"wp-image-107335 alignleft\" src=\"https:\/\/www.klimik.org.tr\/wp-content\/uploads\/2021\/11\/Merck.png\" alt=\"\" width=\"114\" height=\"39\" \/><strong>Amerika Birle\u015fik Devletleri ve Kanada d\u0131\u015f\u0131nda MSD olarak bilinen ila\u00e7 \u015firketi Merck ve orta\u011f\u0131 Ridgeback Bioterap\u00f6tiks taraf\u0131ndan COVID-19 tedavisi i\u00e7in geli\u015ftirilen ve a\u011f\u0131z yoluyla al\u0131nan antiviral bir ila\u00e7 olan Molnupiravir&#8217;in \u0130ngiltere&#8217;de kullan\u0131m onay\u0131 ald\u0131\u011f\u0131 duyuruldu.<\/strong><\/p>\n<p>Molnupiravir&#8217;in (MK-4482, EIDD-2801) \u0130ngiltere&#8217;de kullan\u0131m\u0131 i\u00e7in Birle\u015fik Krall\u0131k \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu&#8217;nun (MHRA) yetki verdi\u011fi bildirildi. Molnupiravir, SARS-CoV-2 tan\u0131 testi pozitif olan ve ciddi hastal\u0131\u011fa yol a\u00e7abilecek en az bir risk fakt\u00f6r\u00fcne sahip yeti\u015fkinlerde hafif ve orta \u015fiddette COVID-19&#8217;u tedavi etmek i\u00e7in yetkilendirilmi\u015f ilk oral antiviral ila\u00e7t\u0131r. Birle\u015fik Krall\u0131k&#8217;ta Molnupiravir i\u00e7in planlanan ticari marka ad\u0131 LAGEVRIO\u00ae olarak bildirilmi\u015ftir; di\u011fer \u00fclkelerdeki ticari marka ad\u0131 ise hen\u00fcz onaylanmam\u0131\u015ft\u0131r. Merck, Molnupiravir&#8217;in Acil Kullan\u0131m \u0130zni (EUA) i\u00e7in ABD G\u0131da ve \u0130la\u00e7 Dairesi (FDA)&#8217;ne yapt\u0131\u011f\u0131 ba\u015fvurunun incelenmekte oldu\u011funu ve\u00a0 Avrupa \u0130la\u00e7 Ajans\u0131&#8217;n\u0131n k\u0131sa s\u00fcre \u00f6nce \u015firketin Pazarlama Yetkilendirme Ba\u015fvurusu i\u00e7in s\u00fcrekli bir inceleme ba\u015flatt\u0131\u011f\u0131n\u0131 duyurdu. Merck, d\u00fcnyadaki di\u011fer d\u00fczenleyici kurumlara ba\u015fvuru g\u00f6ndermek i\u00e7in aktif olarak \u00e7al\u0131\u015fmaya devam etmektedir.<\/p>\n<p><a href=\"https:\/\/www.merck.com\/news\/merck-and-ridgebacks-molnupiravir-an-oral-covid-19-antiviral-medicine-receives-first-authorization-in-the-world\/\"><strong>Bas\u0131n Duyurusu \u0130\u00e7in T\u0131klay\u0131n\u0131z<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amerika Birle\u015fik Devletleri ve Kanada d\u0131\u015f\u0131nda MSD olarak bilinen ila\u00e7 \u015firketi Merck ve orta\u011f\u0131 Ridgeback Bioterap\u00f6tiks taraf\u0131ndan COVID-19 tedavisi i\u00e7in geli\u015ftirilen ve a\u011f\u0131z yoluyla al\u0131nan antiviral bir ila\u00e7 olan Molnupiravir&#8217;in \u0130ngiltere&#8217;de kullan\u0131m onay\u0131 ald\u0131\u011f\u0131 duyuruldu. Molnupiravir&#8217;in (MK-4482, EIDD-2801) \u0130ngiltere&#8217;de kullan\u0131m\u0131 i\u00e7in Birle\u015fik Krall\u0131k \u0130la\u00e7 ve Sa\u011fl\u0131k \u00dcr\u00fcnleri D\u00fczenleme Kurumu&#8217;nun (MHRA) yetki verdi\u011fi bildirildi. Molnupiravir, SARS-CoV-2 tan\u0131 testi pozitif olan ve ciddi hastal\u0131\u011fa yol a\u00e7abilecek en az bir risk fakt\u00f6r\u00fcne sahip yeti\u015fkinlerde hafif ve orta \u015fiddette COVID-19&#8217;u tedavi etmek i\u00e7in yetkilendirilmi\u015f ilk oral antiviral ila\u00e7t\u0131r. Birle\u015fik Krall\u0131k&#8217;ta Molnupiravir i\u00e7in planlanan ticari marka ad\u0131 LAGEVRIO\u00ae olarak bildirilmi\u015ftir; di\u011fer \u00fclkelerdeki ticari marka ad\u0131 [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":5181,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5180"}],"collection":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/comments?post=5180"}],"version-history":[{"count":1,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5180\/revisions"}],"predecessor-version":[{"id":5182,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/posts\/5180\/revisions\/5182"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media\/5181"}],"wp:attachment":[{"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/media?parent=5180"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/categories?post=5180"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.klimik.org.tr\/koronavirus\/wp-json\/wp\/v2\/tags?post=5180"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}